Stockholders’ (Deficit) Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
Jul. 31, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Jul. 01, 2017 |
|
| Stockholders’ (Deficit) Equity (Details) [Line Items] | |||||
| Warrant per share description | 9. Stockholders’ (Deficit) Equity Authorized Common Stock The Company is authorized to issue up to 200,000,000 shares of common stock at par value of $0.001 per share. Issuance of Common Stock and Warrants During July 2021, as a result of its IPO, the Company issued 5,000,000 shares of common stock and 4,000,000 warrants to investors in exchange for cash at $5.00 per unit, consisting of $4.99 per share of common stock and $.0125 per four fifths of a warrant | ||||
| Common stock, shares authorized | 200,000,000 | 200,000,000 | |||
| Common stock par value (in Dollars per share) | $ 0.001 | $ 0.001 | |||
| Shares issued | 62,181 | ||||
| Exchange for cash price, per unit (in Dollars per share) | $ 5 | $ 0.013 | |||
| Warrants term | 5 years | 5 years | |||
| Exercise price (in Dollars per share) | $ 6 | $ 6 | |||
| Proceeds of warrants (in Dollars) | $ 7,500 | ||||
| Converted shares | 736,773 | ||||
| Convertible debt shares granted | 184,193 | ||||
| Description of consulting exercised | employees and consultants exercised a total of 383,721 stock options and the Company received $119,000 in proceeds. A portion of these options were exercised early (prior to vesting), and as of March 31, 2022, 52,414 of the options remained unvested. Proceeds received related to the unvested options of $53,000 at March 31, 2022 were recorded in accrued liabilities on the accompanying balance sheets and will be reclassified to equity as vesting occurs, provided the employees and consultants continue to provide services to the Company. Proceeds received related to the vested portion of options of $31,000 and $7,000 were reclassified to equity at March 31, 2021 and March 31, 2022, respectively. The vested portion of the exercises was 331,300 shares at March 31, 2022. | ||||
| Proceeds received (in Dollars) | $ 31,000 | $ 7,000 | |||
| Common stock voting rights | Each holder of shares of common stock shall be entitled to one vote for each share thereof held. | ||||
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 | |||
| Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | |||
| Common Stock [Member] | |||||
| Stockholders’ (Deficit) Equity (Details) [Line Items] | |||||
| Shares issued | 5,000,000 | ||||
| Common stock price, per share (in Dollars per share) | $ 4.99 | ||||
| Warrants [Member] | |||||
| Stockholders’ (Deficit) Equity (Details) [Line Items] | |||||
| Shares issued | 4,000,000 | ||||
| Purchase of additional warrants shares | 600,000 | ||||